AZD8797, CAS [[911715-90-7]]

Artikelnummer: BYT-ORB1707606
Artikelname: AZD8797, CAS [[911715-90-7]]
Artikelnummer: BYT-ORB1707606
Hersteller Artikelnummer: orb1707606
Alternativnummer: BYT-ORB1707606-1, BYT-ORB1707606-1, BYT-ORB1707606-10, BYT-ORB1707606-100, BYT-ORB1707606-25, BYT-ORB1707606-5, BYT-ORB1707606-50
Hersteller: Biorbyt
Kategorie: Biochemikalien
Alternative Synonym: CX3CR1, CXCR2, AZD 8797, AZD8797, AZD-8797, [125I]-CX3CL1-CX3CR1, 125I-IL-8-CXCR2, KAN-0440567, KAND567
AZD8797 (KAND567) is a selective, orally bioavailable antagonist of human CX3CR1 and CXCR2. It has shown potential in research models to protect against SARS-CoV-2-related neuronal damage and to attenuate migraine-associated nociceptive sensitization and microglial activation in post-seizure rats.
Molekulargewicht: 403.56
Reinheit: 99.68% (May vary between batches)
CAS Nummer: [911715-90-7]
Formel: C19H25N5OS2
Target-Kategorie: CXCR
Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.91 mM),DMSO:100 mg/mL (247.79 mM)
CAS: 911715-90-7